South African patient's acceptance of generic drugs.

Abstract

Access to therapeutic drugs form an integral part of any successful healthcare system. The high cost of drugs, however, remains a barrier to accessibility and improved health to the majority of the South African population1. The promotion of generic drug consumption could potentially be an important cost-saving mechanism in this regard for final consumers, insurance providers, and government. In 2001, the South African government subsequently passed the law which allows generic substitution of branded medicines with generics, provided that the patient approves of the substitution. In the discussion over the use of generic drugs, patient perceptions have often been neglected. Currently very little knowledge exists on the perception and attitudes of South African citizens with regard to the use of generic drugs. An appraisal of the available literature suggests that although patients do not completely have a negative opinion of generic drugs and acceptance is growing, there still exists room for improving perceptions. Similar to several international studies, the South African patient's acceptance of generics is influenced by age, educational level, perceived seriousness of illness, generic drug information, and doctor and pharmacist perceptions. In general, participants with lower incomes and participants with lower levels of education held poorer attitudes toward generic drugs2. Individuals with tertiary education were found to have a more positive attitude toward generics than individuals with no tertiary education3. Patients often confuse “generic brands” of therapeutic drugs with counterfeit products especially due to the cost difference associated with these products. Free generic medication issued by the public health facilities are viewed as inferior, treated with suspicion and regarded as being of poor quality4. There are however citizens who view drug quality as product attributes and expected consequences of taking a particular medicine. Irrespective of whether the drug was a generic, original, supplied for free or purchased from a pharmacy, the drug was considered good quality provided that it treated the symptoms. Studies also consistently show that, participants frequently have very little understanding of generic medicines. Most patients are not adequately informed about the difference or similarities between original and generic drugs by healthcare providers. Additionally patients feel that they have limited influence in the choice of generic substitution. Patients with increased level of education, and those who received proper counselling, were found to be more accepting of generic substitution and tended to view generic drugs as a valuable reform. Patients would be more inclined to choose a generic drug if the decision was supported by their doctor rather than the recommendation of the pharmacist. The use of generic drugs to treat chronic diseases is also received with mixed acceptance. Certain groups of patients viewed the cost saving benefit very positively. South African patients also related quality to the ability of the medication to do what it was prescribed to do. Therefore drugs that treated their symptoms - whether generic or original - were fully accepted provided they fulfilled their role. On the other hand, there were also patients who were not accepting of generics to treat chronic conditions, as they viewed them as inferior, and likely to have greater side effects than original drugs. Some of the concerns amongst chronic drug users were with regard to reduced effect of the drug or new or increased side effects. In addition, chronically ill patients who take several drugs for longer periods of time admitted to feeling unsettled - particularly when being offered different generics each time they purchase their medication. The effect of brand to generic and generic to generic switches leads to intentional non-adherence in erroneous use. This is especially problematic with medication classes that have narrow therapeutic margin like anti-epileptics.